Assessment of diastolic function from velocity-encoded cardiac magnetic resonance data in patients with hypertrophic cardiomyopathy
Golmehr Ashrafpoor(Université Paris Cité), Alban Redheuil(Sorbonne Université), Nadjia Kachenoura(Inserm), Albert Hagège, Élie Mousseaux(MACOM (United States)), Émilie Bollache(Centre National de la Recherche Scientifique), Arshid Azarine(Hôpital Européen Georges-Pompidou), É. Bruguière(Hôpital Européen Georges-Pompidou), Michel Desnos(Hôpital Européen Georges-Pompidou), Sébastien Fontaine(Université Fédérale de Toulouse Midi-Pyrénées), Laurent Macron(Clinique Hartmann)
Cited by 0
Related Papers
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Sports-Related Sudden Death in the General Population
|Circulation|2011|541
Mitral valve disease—morphology and mechanisms
|Nature Reviews Cardiology|2015|387
Computed Tomography Aortic Valve Calcium Scoring in Patients With Aortic Stenosis
|Circulation Cardiovascular Imaging|2018|384
Clinical Profile, Contemporary Management and One-Year Mortality in Patients with Severe Acute Heart Failure Syndromes: The EFICA Study
|European Journal of Heart Failure|2006|351